Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH · NASDAQ Global Market
+$0.13 today
Vol 1.14M · Avg 1.21M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+110.22%
Period High
$16.46
Period Low
$7.47
Latest
$16.46
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.53B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.20B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.92B
Nuvation Bio Inc.
NYSE:NUVB
$1.88B
Stoke Therapeutics, Inc.
NASDAQ:STOK
$1.87B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.67B
Immunocore Holdings plc
NASDAQ:IMCR
$1.47B
Biohaven Ltd.
NYSE:BHVN
$1.43B
MannKind Corporation
NASDAQ:MNKD
$1.21B
Janux Therapeutics, Inc.
NASDAQ:JANX
$854.12M
What is the latest AUPH filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does AUPH have?
Intrinsic Alpha currently shows 20 recent filings for AUPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.